GAS5 and bladder transitional cell carcinoma: (38) encouraged the notion that bladder cancer (BlCa) expressing lower levels of GAS5 than that in adjacent normal tissues, and GAS5 expression in invasive (T1-T4) tumors was significantly attenuated than in superficial Ta tumors.